Home » Stocks » Liquidia Technologies

Liquidia Technologies, Inc. (LQDA)

Stock Price: $4.50 USD -0.06 (-1.21%)
Updated Oct 26, 2020 2:32 PM EDT - Market open

Stock Price Chart

Key Info

Market Cap 169.69M
Revenue (ttm) n/a
Net Income (ttm) -56.62M
Shares Out 37.75M
EPS (ttm) -2.36
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 26, 2020
Last Price $4.50
Previous Close $4.55
Change ($) -0.06
Change (%) -1.21%
Day's Open 4.59
Day's Range 4.44 - 4.71
Day's Volume 578,392
52-Week Range 2.65 - 12.10

More Stats

Market Cap 169.69M
Enterprise Value 166.87M
Earnings Date (est) Oct 28, 2020
Ex-Dividend Date n/a
Shares Outstanding 37.75M
Float 22.74M
EPS (basic) -2.45
EPS (diluted) -2.36
FCF / Share -1.93
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 1.98M
Short Ratio 6.67
Short % of Float 8.72%
Beta 0.47
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 19.20
Revenue n/a
Operating Income -55.63M
Net Income -56.62M
Free Cash Flow -54.92M
Net Cash 2.82M
Net Cash / Share 0.07
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -69.44%
ROE -276.46%
ROIC -269.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (2)

Buy 2
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(144.72% upside)
Current: $4.50
Target: 11.00
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth198.2%-62.7%-45.08%-
Gross Profit7.262.596.9412.30
Operating Income-46.82-34.87-28.03-15.86
Net Income-47.58-53.14-29.15-15.93
Shares Outstanding18.487.160.560.44
Earnings Per Share-2.59-7.51-51.78-36.42
Operating Cash Flow-48.28-31.83-24.29-13.95
Capital Expenditures-1.85-0.87-2.54-2.89
Free Cash Flow-50.13-32.70-26.83-16.83
Cash & Equivalents55.8039.533.421.44
Total Debt24.4212.7722.158.68
Net Cash / Debt31.3826.76-18.73-7.24
Book Value34.9518.69-33.69-18.25
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Liquidia Technologies, Inc.
Country United States
Employees 64
CEO Neal F. Fowler

Stock Information

Ticker Symbol LQDA
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: LQDA
IPO Date July 26, 2018


Liquidia Technologies, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of novel products which utilize PRINT technology to transform the lives of patients. Its lead product candidate is LIQ861, an inhaled dry powder formulation of treprostinil that is in Phase III clinical trials for the treatment of pulmonary arterial hypertension. The company also develops LIQ865, which completed Phase 1 clinical trials for the treatment of local post-operative pain. It has collaboration agreement with the University of North Carolina. Liquidia Technologies, Inc. was founded in 2004 and is headquartered in Morrisville, North Carolina.